As of Nov 19, 2026, 1 of 2 active firms rate NGVT a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
NGVT EPS & revenue forecast
EPS · NEXT QUARTER
$1.21
Range $1.13 – $1.28 · 2 analysts · +5% YoY
Next period, 2 analysts expect Ingevity Corp to earn $1.21 a share (range $1.13 – $1.28), versus $1.15 a year earlier. Full-year consensus is $5.39, growing to $5.96 the year after.
REVENUE · NEXT QUARTER
$252.3M
Range $250.0M – $254.7M · 2 analysts · -2% YoY
Revenue is expected to reach $252.3M (range $250.0M – $254.7M), -2.2% year-over-year. Full-year consensus is $1.1B, rising to $1.1B next year.
Top analysts covering Ingevity Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NGVT.
#1
John McNulty
BMO Capital · Rank #94
Buy
$70.00+20.1% to target
Overall win rate
46%
+ Follow
#2
Michael Sison
Wells Fargo · Rank #197
Neutral
$75.00+28.7% to target
Overall win rate
44%
+ Follow
NGVT stock forecast FAQ
What is NGVT's average 12-month price target?+
The 2 active firms with a live target average $72.50 for Ingevity Corp over the next 12 months, ranging from a $75.00 high to a $70.00 low, as of Nov 19, 2026.
Is NGVT stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for NGVT?+
The Street-high target is $75.00 (Wells Fargo), and the Street-low is $70.00 (BMO Capital). The average of all 2 active-firm targets is $72.50.
How many active Wall Street firms cover NGVT?+
2 active firms have a recognized rating on Ingevity Corp as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering NGVT?+
Among analysts who currently cover NGVT, John McNulty of BMO Capital has the strongest overall Quantellect track record (Rank #94). Their current call is Buy with a $70.00 target.
What is Ingevity Corp's projected EPS for next quarter?+
The consensus estimate is $1.21 per share (range $1.13 – $1.28) across 2 analysts. Full-year EPS is projected at $5.39, rising to $5.96 the following year.
How much revenue is Ingevity Corp expected to report next quarter?+
Consensus revenue is $252.3M (range $250.0M – $254.7M). Full-year revenue is projected at $1.1B, growing to $1.1B next year.
Have analysts been upgrading or downgrading NGVT lately?+
As of Nov 19, 2026, 1 of 2 active firms rate NGVT a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NGVT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.